NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $236,621 | +0.6% | 2,323 | -0.3% | 0.17% | +1.8% |
| Q2 2023 | $235,121 | +9.7% | 2,330 | 0.0% | 0.16% | +5.8% |
| Q1 2023 | $214,360 | +1.4% | 2,330 | 0.0% | 0.16% | -2.5% |
| Q4 2022 | $211,377 | +19.4% | 2,330 | 0.0% | 0.16% | +4.6% |
| Q3 2022 | $177,000 | -10.2% | 2,330 | 0.0% | 0.15% | -1.9% |
| Q2 2022 | $197,000 | +0.5% | 2,330 | +4.5% | 0.16% | +16.4% |
| Q1 2022 | $196,000 | +0.5% | 2,230 | 0.0% | 0.13% | +6.3% |
| Q4 2021 | $195,000 | -12.6% | 2,230 | -18.3% | 0.13% | -18.7% |
| Q3 2021 | $223,000 | +14.4% | 2,730 | +27.9% | 0.16% | +16.5% |
| Q2 2021 | $195,000 | +6.6% | 2,135 | 0.0% | 0.13% | +5.6% |
| Q1 2021 | $183,000 | -9.0% | 2,135 | 0.0% | 0.13% | -15.4% |
| Q4 2020 | $201,000 | – | 2,135 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |